## *Slide 2: Proposed Solution (Kamran)*

Thank you, Anshul.

Respected judges, I am Kamran, and today I am presenting our proposed solution, **QuantumX**.

Our project is a Hybrid Quantum-Classical Machine Learning Platform for Early Disease Detection.

Let me first explain the problem. In medical diagnosis, early detection is very important. If a disease is detected early, doctors may get more time to plan treatment and manage the patient's condition.

However, medical data is not always simple. For example, a patient's disease risk may depend on many things together, such as age, blood pressure, cholesterol, genetic information, and other clinical features. Sometimes, the important signal is very small, and it is hidden inside a large amount of data. This creates a challenge for machine learning models.

### First, the problem with classical ML
On the left side of this slide, we show the limitations of classical machine learning. Classical ML models, such as Random Forest, SVM, and XGBoost, run on normal computers and are already very useful in healthcare.

But when the data becomes very complex, some important relationships between features may be difficult to capture. For example, in breast cancer detection, two cells may look very similar. A small difference in their shape, nucleus, or texture may be important for identifying whether the cell is benign or malignant.

If the model cannot learn these subtle differences properly, it may produce a false negative. A false negative means the disease is actually present, but the model predicts that it is not present. This is especially critical in early disease detection because missing a disease may delay further medical examination.

### Second, why this problem becomes difficult
Now, look at the 3D feature-space graph. Here, different features are represented as different dimensions. The problem is that some benign and malignant samples may overlap.

This means that the boundary between the two classes is not always simple. A classical model may find it difficult to separate these overlapping samples correctly. The result can be missed cases, especially when the disease-related pattern is subtle.

So, the main challenge is not simply: *“Can we build a machine learning model?”*  
The real challenge is: *“Can we capture complex patterns accurately enough to reduce missed disease cases?”*

### Third, our proposed solution
Now, let me explain what QuantumX actually is.

QuantumX is a medical research platform we built to test whether quantum computing can genuinely improve early disease detection. In our platform, a user can enter patient clinical data—like blood work, vitals, or cellular measurements—and run both standard AI and quantum tools together. The system doesn't just give a prediction; it explains which health factors caused that result and compares both methods side by side on screen. That way, doctors and researchers have a practical software platform where they can see the actual evidence for themselves rather than just guessing.

### Fourth, core features of our prototype
To deliver this experience, our working prototype provides four main features:

First, **Interactive Disease Prediction**—where clinicians can enter patient test metrics and immediately receive early risk assessments.

Second, **AI Explanation**—the system provides clear clinical insights and visual charts, so doctors understand exactly why an alert was triggered.

Third, **Side-by-Side Benchmarking**—researchers can test and compare classical AI against quantum models on accuracy and false negative rates.

Fourth, **Quantum Hardware Support**—the platform connects directly to both local simulators and real quantum processors like IBM Quantum.

### Finally, our core objective
Our primary goal is to prevent late detection and reduce diagnostic errors, helping clinicians catch critical illnesses at their earliest and most treatable stages.

To prove this scientifically, QuantumX is built to benchmark our hybrid approach directly against classical models across three key areas: accuracy, computational efficiency, and generalization performance on real biomedical data.

That defines the true scope and purpose of QuantumX.

To explain our technical approach and system architecture, I would now like to hand over back to **Anshul**.

### Passes to Anshul (Slide 3) -->